| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P819 | ADS bibcode | 2017PLoSO..1278611O |
| P356 | DOI | 10.1371/JOURNAL.PONE.0178611 |
| P932 | PMC publication ID | 5462396 |
| P698 | PubMed publication ID | 28591151 |
| P2093 | author name string | Mai Selim | |
| Eman Farrag | |||
| Arwa Hasanine | |||
| Azza Selim | |||
| Mohamed Hosny Osman | |||
| Mohamed Samy Osman | |||
| P2860 | cites work | Another shortcut method for calculating the confidence interval of a Poisson variable (or of a standardized mortality ratio) | Q93588322 |
| Global battle against cancer won't be won with treatment alone--effective prevention measures urgently needed to prevent cancer crisis | Q95375245 | ||
| Digitoxin medication and cancer; case control and internal dose-response studies | Q21261338 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | Q27860581 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men | Q28142458 | ||
| Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5 | Q28277569 | ||
| Reproductive factors and risk of primary brain tumors in women | Q28387379 | ||
| Cardiac glycosides use and the risk of lung cancer: a nested case-control study | Q28392316 | ||
| Drug repositioning: identifying and developing new uses for existing drugs | Q29614779 | ||
| Regulation of cell death: the calcium-apoptosis link | Q29615554 | ||
| Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function | Q33359970 | ||
| Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth | Q33385608 | ||
| Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis. | Q33566322 | ||
| Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis. | Q40559933 | ||
| Up-regulation of Na(+),K(+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer | Q40570320 | ||
| Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County | Q40728872 | ||
| Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. | Q40793790 | ||
| Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study. | Q40938507 | ||
| Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up | Q41277483 | ||
| Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study | Q41472414 | ||
| Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studies | Q41656031 | ||
| Risk factors for male breast cancer--a case-control study from Scandinavia | Q43706470 | ||
| Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells | Q43756233 | ||
| Mechanism of interaction of digitalis with estradiol binding sites in rat uteri | Q43910035 | ||
| Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol | Q43955683 | ||
| Risk factors for male breast cancer: a Franco-Swiss case-control study | Q44627458 | ||
| A case-control study of male breast cancer. | Q46002281 | ||
| Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort | Q46463027 | ||
| Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma | Q46570569 | ||
| Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. | Q46968214 | ||
| A cohort study of digoxin exposure and mortality in men with prostate cancer | Q47797325 | ||
| Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. | Q52519745 | ||
| Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis | Q33836078 | ||
| Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model | Q33850511 | ||
| Management of advanced prostate cancer | Q33856417 | ||
| Retracted: Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies | Q34128263 | ||
| Alcohol drinking may increase risk of breast cancer in men: a European population-based case-control study | Q34336850 | ||
| Digitoxin activates EGR1 and synergizes with paclitaxel on human breast cancer cells | Q34381147 | ||
| Interaction of Digitalis and Spironolactone with Human Sex Steroid Receptors | Q34383043 | ||
| Epidemiology of male breast cancer | Q34387721 | ||
| Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s | Q34588433 | ||
| A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment | Q35581883 | ||
| The role of estrogen in the initiation of breast cancer | Q35698844 | ||
| Digoxin use and the risk for colorectal cancer | Q35917969 | ||
| Estrogen plus progestin and colorectal cancer incidence and mortality | Q36368906 | ||
| Cohort study of risk factors for breast cancer in post menopausal women | Q36844269 | ||
| Cardiotonic steroids on the road to anti-cancer therapy | Q36913651 | ||
| Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer | Q37000743 | ||
| Therapeutic significance of estrogen receptor β agonists in gliomas | Q37039582 | ||
| Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study | Q37131343 | ||
| Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use | Q37306222 | ||
| Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists | Q37428887 | ||
| Is digoxin use for cardiovascular disease associated with risk of prostate cancer? | Q37604348 | ||
| Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-analysis | Q37661768 | ||
| Molecular pathways: digoxin use and estrogen-sensitive cancers--risks and possible therapeutic implications | Q37988459 | ||
| Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials. | Q38113122 | ||
| Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix | Q38437108 | ||
| Aspirin use and risk of breast cancer: systematic review and meta-analysis of observational studies | Q38575448 | ||
| Global estimates of cancer prevalence for 27 sites in the adult population in 2008. | Q38920305 | ||
| Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer | Q39553740 | ||
| Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor. | Q39654369 | ||
| Therapeutic and toxic effects of digitalis: William Withering, 1785. | Q39754968 | ||
| Digoxin use after diagnosis of prostate cancer and survival: a population-based cohort study | Q39794208 | ||
| Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells. | Q40044677 | ||
| Use of cardiac glycosides and risk of glioma | Q40154465 | ||
| Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: A SEER-Medicare database analysis | Q40184563 | ||
| Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. | Q40259456 | ||
| Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial | Q40316207 | ||
| Digitalis-induced signaling by Na+/K+-ATPase in human breast cancer cells. | Q40480287 | ||
| Digoxin use after diagnosis of colorectal cancer and survival: a population-based cohort study | Q40545380 | ||
| Digoxin use and the risk of breast cancer in women. | Q53082336 | ||
| Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia. | Q53149725 | ||
| Digitalis and breast cancer | Q53806215 | ||
| Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells. | Q55065912 | ||
| Drugs and colon cancer | Q57268456 | ||
| Is digoxin a breast cancer risk factor? | Q58181734 | ||
| Breast cancer and use of rauwolfia and other antihypertensive agents in hypertensive patients: a nationwide case-control study in Finland | Q67865951 | ||
| Suppression of breast cancer cells by cardiac glycosides | Q68016642 | ||
| Estrogen and progesterone receptors in ovarian cancer | Q68697626 | ||
| Nonestrogenic drugs and breast cancer | Q70443350 | ||
| Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer | Q70474869 | ||
| Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma | Q72369654 | ||
| Gynecomastia during digitalis therapy; report of eight additional cases with liver-function studies | Q73074432 | ||
| Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells | Q74088025 | ||
| Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia | Q78519673 | ||
| Phase 1 trial of Anvirzel in patients with refractory solid tumors | Q83956808 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiac glycoside | Q422238 |
| observational study | Q818574 | ||
| neoplasm | Q1216998 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e0178611 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies | |
| P478 | volume | 12 |
| Q89304755 | Pharmacologic Management of Cancer Therapeutics-Induced Cardiomyopathy in Adult Cancer Survivors | cites work | P2860 |
Search more.